Delivery Order SPE2DB22D1041-SPE2DB25FUAN7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,145.66 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement. The place of performance is listed as Conshohocken, Pennsylvania, which coincides with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,525.28 to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Exforge 5-160 mg tablets (30-count unit). This firm fixed-price contract, with a completion date of May 29, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-160 mg tablets (30-count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $1,230.19 and utilizes firm fixed price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,117.93. This firm fixed price delivery order, awarded on May 15, 2025, represents a non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $5,600.01 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count packaging) under a firm fixed-price contract. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUAN7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,085.02 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Exforge 10-160 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by May 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and runs through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this delivery order based on its established capability to meet federal procurement requirements. The company routinely fulfills pharmaceutical supply needs for military and veteran healthcare systems through the DLA Medical Supply Chain, delivering brand-name and generic medications across multiple therapeutic domains. As a critical federal vendor, AmerisourceBergen maintains consistent relationships with government healthcare customers including the Defense Health Agency and U.S. Coast Guard, supporting the broader military medical logistics network through flexible and scalable contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.1k | 5/6/25 |